Third Harmonic Bio

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell THRD and other ETFs, options, and stocks.

About THRD

Third Harmonic Bio, Inc. develops pharmaceutical products for the treatment of allergic and immune diseases and disorders. It focuses on the development of the next wave of medicine for the treatment of allergic and inflammatory diseases.

CEO

Natalie C. Holles

CEONatalie C. Holles

Employees

Employees53

Headquarters

San Francisco, California

HeadquartersSan Francisco, California

Founded

2019

Founded2019

Employees

Employees53

THRD Key Statistics

Market cap

245.04M

Market cap245.04M

Price-Earnings ratio

-4.37

Price-Earnings ratio-4.37

Dividend yield

—

Dividend yield—

Average volume

246.11K

Average volume246.11K

High today

$5.50

High today$5.50

Low today

$5.41

Low today$5.41

Open price

$5.45

Open price$5.45

Volume

193.82K

Volume193.82K

52 Week high

$16.02

52 Week high$16.02

52 Week low

$3.18

52 Week low$3.18

People also own

Based on the portfolios of people who own THRD. This list is generated using Robinhood data, and it’s not a recommendation.